This guy is sharp and to the point Now in China Portfolio manager. Worked in US for major investment places.
9 min long. He uses 2 drugs as an example.
https://youtu.be/QYP5urTEWIAHigh prices for Ozempic and Wegovy, two European-made weight-loss drugs, expose our corrupted system
Ozempic and Wegovy are successful weight loss drugs, manufactured by Norsk Nordisk, a Danish company. Both are highly effective against diabetes.
Critics complain about the pricing on these drugs in the United States, compared to peer countries.
The monthly cost to US patients is over 10 times for patients in the UK, which is higher still than the burdens on patients in Australia and France.The reason for the huge price disparities, however, is surprising, and sinister: it is primarily not driven by price-gouging drug companies, but by rent-seeking US health insurers. By creating a new sub-industry called
Pharmacy Benefit Managers, and demanding "rebates" from drug companies hoping to sell in the US market, health insurers get around the profit caps established under the ObamaCare law, and enjoy billions of dollars in risk-free profits, with shocking cost increases borne by American patients, hospitals, and federal and state governments.
Correction at 00:37: Novo Nordisk is a Danish company, not a Dutch company. Apologies.
